Page last updated: 2024-11-02

oxymetazoline and Blood Loss, Postoperative

oxymetazoline has been researched along with Blood Loss, Postoperative in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrons, RO1
Vansickle, RA1
Ouanes, JP1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Nasotracheal Intubation Over a Bougie Placed Via a Subsequently Removed Nasal Trumpet[NCT03003455]257 participants (Actual)Interventional2012-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for oxymetazoline and Blood Loss, Postoperative

ArticleYear
Seldinger technique for nasal intubation: a case series.
    Journal of clinical anesthesia, 2016, Volume: 34

    Topics: Aged, 80 and over; Anesthesia, General; Anesthetics, Local; Child, Preschool; Glossectomy; Humans; I

2016